Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence
Abstract Since the 2019 novel coronavirus disease (COVID-19) outbreak in 2019 and the pandemic continues for more than one year, a vast amount of drug research has been conducted and few of them got FDA approval. Our objective is to prioritize repurposable drugs using a pipeline that systematically...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/62b2501ae06e46a290cae495d7afa94f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|